# Neurocognitive Assessment in Long-Term Survivors of Lymphoma

> **NCT07652476** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 100 (estimated)

## Conditions studied

- Classic Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma (DLBCL)
- Primary Mediastinal B Cell Lymphoma

## Interventions

- **DRUG:** anthracycline containing regimen

## Key facts

- **NCT ID:** NCT07652476
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652476, "Neurocognitive Assessment in Long-Term Survivors of Lymphoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*